Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Shockwave Therapy for Belly Fat in Young and Middle-Aged Adults

Tests shockwave therapy, with diet and exercise, for abdominal obesity in adults.

Plain-language title generated from the registry record
Registry title: Metabolic Effectiveness of Extracorporeal Shockwave on Abdominal Adiposity

Key facts

Where
Shibīn al Kawm, EgyptSee the site

Where in Egypt

  • Shebin ElKom Teaching HospitalShibīn al Kawm, EgyptNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Cairo University
Trial code
NCT07686601
Record updated
7 July 2026
Original description
Egyptian Ministry of Health and Population's Preventive Sector, have named obesity as one of the top contributors to the national mortality and morbidity. Abdominal obesity is a strong predictor of metabolic disorders and premature mortality. Visceral fat is metabolically active and sensitive for lipolysis, unless it is more insulin resistant. It is well-known that overweight and/ or obesity is associated with overactivated proinflammatory cytokines those overactivated inflammatory process thus led to organs dysfunction across persistent low-grade inflammations . Recently, extracorporeal shock wave represents a promising, non-invasive management strategy supporting the treatment of a variety of conditions related to plastic surgery. As well, it displayed a good safety profile with no serious adverse events .Read full original descriptionShow less

Metabolic Effectiveness of Extracorporeal Shockwave on Abdominal Adiposity

Egyptian Ministry of Health and Population's Preventive Sector, have named obesity as one of the top contributors to the national mortality and morbidity. Abdominal obesity is a strong predictor of metabolic disorders and premature mortality. Visceral fat is metabolically active and sensitive for lipolysis, unless it is more insulin resistant. It is well-known that overweight and/ or obesity is associated with overactivated proinflammatory cytokines those overactivated inflammatory process thus led to organs dysfunction across persistent low-grade inflammations . Recently, extracorporeal shock wave represents a promising, non-invasive management strategy supporting the treatment of a variety of conditions related to plastic surgery. As well, it displayed a good safety profile with no serious adverse events .

The need of this study develops from the lack in the quantitative knowledge and information regarding overall metabolic effectiveness of the Extracorporeal Shockwave on abdominal adiposity.

Inclusion: This study will be delimited by:; Age > 18years old; All of them suffered from abdominal obesity; All have waist/ hip ratio of > 0.85 and their waist circumference > 90 cm.

Exclusion: Patients who received pharmacological drugs for controlling obesity were excluded; Patients with diabetes mellitus, heart and/ or vascular, renal, hepatic, pulmonary, neurological, psychological, and or mental disorders are excluded; Patients who had autoimmune diseases were excluded; Patients with hypertension, metal or electronic implants were excluded; Patients who have cancer were excluded; Patients who had the following features will be excluded from the study:; Patients, who have intra-abdominal mesh and/ or unrepaired abdominal hernia were excluded; Patients who have scars, open lesions and wounds at treatment area were excluded; Patients who have any intervention to lose weight or body contouring within the last 6 months (diet, exercise or body contouring devices) were excluded.

ClinicalTrials.gov NCT07686601